Social Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Social Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2022-08-30FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for a sertraline hydrochloride generic from Quallent Pharmaceuticals Health LLC, updating the labeli…
-
FDA approval · 2022-08-30FDA Approved: VENLAFAXINE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application (ANDA) for venlafaxine from Zydus Lifesciences Limited, enabling generic access to the antidepressant.
-
FDA approval · 2022-08-15FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) from Viatris Specialty LLC.
-
FDA approval · 2022-08-09FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Venlafaxine Hydrochloride (extended-release) submitted by Chartwell RX, LLC.
-
FDA approval · 2022-06-29FDA Approved: VENLAFAXINE — Original Application (Almatica Pharma LLC)
The FDA approved an Original Application for Venlafaxine from Almatica Pharma LLC. Venlafaxine is indicated for major depressive disorder, g…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-23Clinical Trial Update: 1/2 A Multi-site Systems Intervention for Unemployed Persons With Social Anxiety [NA]
A completed multi-site trial evaluating a systems intervention for unemployed individuals with social anxiety disorder; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine [Phase 2]
A Phase 2 trial evaluating physician and parent decisions to treat selective mutism with fluoxetine has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: Efficacy of an Attention Guidance VR Intervention for Social Anxiety Disorder [NA]
A terminated clinical trial evaluating an attention guidance VR intervention for social anxiety disorder with posted results.
-
FDA approval · 2022-02-25FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride from Zydus Lifesciences Limited, applying to the generic product.
-
FDA approval · 2022-01-19FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)
The FDA granted a supplemental approval for paroxetine hydrochloride (paroxetine) from NorthStar Rx LLC under an ANDA. This approval confirm…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Treatments for Anxiety: Meditation and Escitalopram [Phase 4]
Phase 4 trial update examining meditation and escitalopram for anxiety disorders, completed.
-
FDA approval · 2021-11-02FDA Approved: PAROXETINE — Original Application (Chartwell RX, LLC.)
FDA approved a generic paroxetine product under an original ANDA submitted by Chartwell RX, LLC.
-
FDA approval · 2021-10-04FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Alvogen, Inc.)
FDA approves the sertraline hydrochloride generic under an Original Application filed by Alvogen, Inc. The approval enables marketing of a g…
-
FDA approval · 2021-09-21FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Venlafaxine (venlafaxine hydrochloride) from BluePoint Laboratories, confirming the approval of …
-
FDA approval · 2021-09-21FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for venlafaxine from Sun Pharmaceutical Industries (ANDA078627).
-
FDA approval · 2021-09-21FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic Venlafaxine manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceutica…
-
FDA approval · 2021-09-21FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc. The approval pertains to changes t…
-
FDA label_change · 2021-09-20FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
FDA approved a supplemental application for Zoloft (sertraline hydrochloride) submitted by Roerig to update the product labeling.
-
FDA approval · 2021-09-20FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2021-09-20FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for Venlafaxine hydrochloride from Vertical Pharmaceuticals, LLC.
-
FDA label_change · 2021-09-20FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA notice of a supplemental labeling application for VENLAFAXINE by Alembic Pharmaceuticals Inc.
-
FDA approval · 2021-09-03FDA Approved: VENLAFAXINE — Supplemental Application (Cadila Pharmaceuticals Limited)
FDA approved a supplemental application for Venlafaxine from Cadila Pharmaceuticals Limited.
-
FDA approval · 2021-09-03FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for venlafaxine (generic) from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., approv…
-
FDA approval · 2021-09-03FDA Approved: PAROXETINE — Original Application (ANI Pharmaceuticals, Inc.)
ANI Pharmaceuticals received FDA approval for an original ANDA application for paroxetine, a generic antidepressant.
-
FDA approval · 2021-09-02FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for venlafaxine by Sun Pharmaceutical Industries, Inc.